title: In vitro efficacy of cefazolin and povidone-iodine 5% in eradicating microbial organisms adhered to broad scleral buckles.
authors.forename: Joveeta
authors.initials: J
authors.lastname: Joseph
authors.forename: Avinash
authors.initials: A
authors.lastname: Pathengay
authors.forename: Vincent
authors.initials: V
authors.lastname: Michael
authors.forename: Biju
authors.initials: B
authors.lastname: Raju
authors.forename: Savitri
authors.initials: S
authors.lastname: Sharma
authors.forename: Taraprasad
authors.initials: T
authors.lastname: Das
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000891:Anti-Infective Agents, Local / Q000494:pharmacology*; D001231:Aspergillus flavus / Q000254:growth & development; D001419:Bacteria / Q000254:growth & development*; D001422:Bacterial Adhesion / Q000187:drug effects*; D002437:Cefazolin / Q000494:pharmacology*; D015169:Colony Count, Microbial; D015818:Eye Infections, Bacterial / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008826:Microbial Sensitivity Tests; D016926:Mycobacterium chelonae / Q000254:growth & development; D011206:Povidone-Iodine / Q000494:pharmacology*; D016459:Prosthesis-Related Infections / Q000209:etiology / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000254:growth & development; D012591:Scleral Buckling / Q000009:adverse effects / Q000295:instrumentation*; D013212:Staphylococcus epidermidis / Q000254:growth & development
chemical_list: D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D011206:Povidone-Iodine; D002437:Cefazolin